Can Breast Cancer Patients Survive Long-Term Without Surgery?

 


For many people, surgery has long been viewed as the essential step in curing cancer. The common belief is simple: if the tumor can be removed, there is hope for a cure. However, advances in modern cancer therapy are beginning to challenge this traditional view.

With the rapid development of neoadjuvant therapy — treatment given before surgery — some breast cancer patients are achieving remarkable responses. In certain cases, tumors completely disappear after drug treatment alone, raising an important question: If no cancer can be found, is surgery always necessary?

A recent study led by MD Anderson Cancer Center explored this possibility in patients with early-stage breast cancer. The study focused on patients with triple-negative breast cancer or HER2-positive breast cancer who had undergone standard neoadjuvant therapy.

After treatment, researchers performed image-guided needle biopsies of both the original tumor site and surrounding lymph nodes. Among the 50 patients enrolled in the study, 31 achieved a pathological complete response (pCR), meaning no remaining cancer cells could be detected in the biopsy samples.

Instead of proceeding directly to surgery, these 31 patients received whole-breast radiation therapy alone. After a median follow-up period of 26.4 months, none of the patients experienced cancer recurrence, and the recurrence-free survival rate remained 100%.

The lead investigator, Dr. Henry Kuerer, described this approach as the ‘ultimate form of breast-conserving therapy,’ where cancer may potentially be eradicated using systemic therapy without the need for surgery.

At the same time, researchers emphasized that this strategy is still experimental. Standard breast cancer surgery remains the current recommended treatment. Longer follow-up and larger clinical studies are still needed before surgery-free treatment can become part of routine clinical practice.

Even so, the study highlights how rapidly cancer treatment is evolving. Advances in chemotherapy, targeted therapy, immunotherapy, and imaging are increasingly allowing physicians to tailor treatment to individual patients. In the future, some patients may be able to avoid surgery altogether while still achieving excellent long-term outcomes.

Reference Study

Kuerer HM et al. “Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy.” The Lancet Oncology (2023).
Study link: https://pubmed.ncbi.nlm.nih.gov/36856291/

This article is intended for educational and informational purposes only and should not be considered medical advice. Patients should always discuss treatment decisions with qualified medical professionals.


Comments

Popular posts from this blog

Why Is Pancreatic Cancer So Difficult to Treat — and Where Is the Hope